Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

US Press Releases


NASDAQ |  NYSE |  OTC
6/16/2024
Order by:

Reset Filters
ROSEN, A LEADING LAW FIRM, Encourages 2U, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWOU
8:00:00 AM
06/16/2024

Class Action Filed Against Autodesk, Inc. (ADSK) - June 24, 2024 Deadline to Join - Contact Levi & Korsinsky
8:00:00 AM
06/16/2024

Levi & Korsinsky Notifies Shareholders of Autodesk, Inc.(ADSK) of a Class Action Lawsuit and an Upcoming Deadline
8:00:00 AM
06/16/2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders
8:00:00 AM
06/16/2024

Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
8:00:00 AM
06/16/2024

Investors in AXT, Inc. Should Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - AXTI
8:00:00 AM
06/16/2024

AXT, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - AXTI
8:00:00 AM
06/16/2024

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
7:56:00 AM
06/16/2024

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
7:44:00 AM
06/16/2024

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
7:00:00 AM
06/16/2024

A Shareholder alert for AXT Inc was sent by Bronstein, Gewirtz and Grossman, LLC to Lead Class Action Lawsuit!
7:00:00 AM
06/16/2024